- Home
- IIF vs KRRO Comparison
IIF vs KRRO Comparison
Compare IIF & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IIF
- KRRO
- Stock Information
- Founded
- IIF 1993
- KRRO 2014
- Country
- IIF United States
- KRRO United States
- Employees
- IIF N/A
- KRRO N/A
- Industry
- IIF Trusts Except Educational Religious and Charitable
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- IIF Finance
- KRRO Health Care
- Exchange
- IIF Nasdaq
- KRRO Nasdaq
- Market Cap
- IIF 228.9M
- KRRO 209.6M
- IPO Year
- IIF N/A
- KRRO 2019
- Fundamental
- Price
- IIF $25.74
- KRRO $18.09
- Analyst Decision
- IIF
- KRRO Strong Buy
- Analyst Count
- IIF 0
- KRRO 7
- Target Price
- IIF N/A
- KRRO $106.33
- AVG Volume (30 Days)
- IIF 45.4K
- KRRO 115.1K
- Earning Date
- IIF 01-01-0001
- KRRO 05-13-2025
- Dividend Yield
- IIF 13.94%
- KRRO N/A
- EPS Growth
- IIF N/A
- KRRO N/A
- EPS
- IIF N/A
- KRRO N/A
- Revenue
- IIF N/A
- KRRO $2,271,000.00
- Revenue This Year
- IIF N/A
- KRRO N/A
- Revenue Next Year
- IIF N/A
- KRRO $20.00
- P/E Ratio
- IIF N/A
- KRRO N/A
- Revenue Growth
- IIF N/A
- KRRO N/A
- 52 Week Low
- IIF $18.95
- KRRO $11.13
- 52 Week High
- IIF $24.41
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- IIF 65.12
- KRRO 53.28
- Support Level
- IIF $22.71
- KRRO $13.07
- Resistance Level
- IIF $26.23
- KRRO $20.11
- Average True Range (ATR)
- IIF 0.53
- KRRO 2.00
- MACD
- IIF 0.24
- KRRO 0.95
- Stochastic Oscillator
- IIF 86.35
- KRRO 77.51
About IIF Morgan Stanley India Investment Fund Inc.
Morgan Stanley India Investment Fund, Inc. is the United States based non-diversified, closed-end management investment company. Its investment objective is to achieve long-term capital appreciation through investment in equity securities of Indian Issuers. The company's portfolio of investments consists of the investment in different sectors such as auto components, banks, capital markets, construction and engineering, pharmaceuticals and others.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.